Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-24-012961
Filing Date
2024-11-21
Accepted
2024-11-21 18:36:04
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 27715
2 filename2.txt TEXT-EXTRACT 1209
  Complete submission text file 0000000000-24-012961.txt   40197
Mailing Address 100 SUMMIT DR BURLINGTON MA 01803
Business Address 100 SUMMIT DR BURLINGTON MA 01803 781-439-5551
Neuphoria Therapeutics Inc. (Filed for) CIK: 0001191070 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: UPLOAD | File No.: 333-283306
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)